Explore prevent.org

Business & Health

Research

Policy & Advocacy

Clinical Prevention

Community Prevention

Prevention Matters Blog
Prevention Matters Podcast
Aspirin Use
Promoting Aspirin Use to Prevent Cardiovascular Disease
 
In its landmark study ranking the value of clinical preventive services, Partnership for Prevention found that counseling about regular aspirin use is one of the highest value preventive services clinicians can provide.

Currently, less than half of all adults who could benefit from low-dose aspirin take it on a regular basis. If this was increased to 90 percent, an additional 45,000 lives would be saved each year. In addition, widespread counseling about aspirin use would result in medical savings of $70 per person advised.

Partnership for Prevention has formed the Council on Aspirin for Health and Prevention (CAHP) to guide a multi-pronged initiative to increase the number of Americans who are using aspirin to reduce their risk of heart disease and stroke. The CAHP recently developed and launched www.aspirinproject.org, an educational website for consumers, health care providers, and policymakers about low-dose aspirin for primary prevention. Aspirin can save lives, preventing heart attack, stroke, and cancer, but is not right for everyone. At www.aspirinproject.org, consumers and health care providers can get key information about aspirin.


News
  • Partnership for Prevention and the Council on Aspirin for Health and Prevention issued a public statement in response to the FDA's rejection of aspirin for primary prevention of cardiovascular disease.
  • The Council on Aspirin for Health and Prevention has released www.aspirinproject.org, an educational website for consumers, health care providers, and policymakers. The site contains many resources (e.g., fact sheets, videos, risk calculators, evidence summaries) to help consumers and providers decide together if aspirin for primary prevention is the right choice. Sign up to receive Aspirin in the News, a monthly compilation of key articles about aspirin.
Guidelines/Recommendations
 
Partnership for Prevention’s Council on Aspirin for Health and Prevention

Partnership for Prevention has established the Council on Aspirin for Health and Prevention (CAHP) to guide Partnership’s aspirin-related activities. Members of the CAHP are listed below.

George K. Anderson, MD, MPH
Major General, U.S. Air Force, Medical Corps (retired)

Kathy Berra, MSN, ANP
Cardiovascular Nurse Practitioner
Stanford Prevention Research Center
Stanford University School of Medicine

Andrew T. Chan, MD, MPH
Associate Professor, Department of Medicine, Harvard Medical School
Attending Gastroenterologist, Massachusetts General Hospital
 
Gerald Fletcher, MD
Liaison for Outreach, Health and Wellness, Mayo Clinic Florida
Professor of Medicine, CVD, Mayo Clinic College of Medicine

Augustus O. Grant, MD, PhD
Professor of Medicine
Vice Dean for Faculty Enrichment, School of Medicine
Duke University

William Miser, MD, MA
Professor of Family Medicine
Director, Medical Residency Program, Department of Family Medicine
Ohio State University

Nilay Shah, PhD
Associate Professor of Health Services Research
Division of Health Care Policy and Research
Mayo Clinic

Jason M. M. Spangler, MD, MPH
Executive Director, Medical Policy
Amgen, Inc. 

Randall S. Stafford, MD, PhD
Professor of Medicine
Director, Program on Prevention Outcomes and Practices, Stanford Prevention Research Center
Stanford University

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-Director, UCLA Program in Preventive Cardiology
University of California, Los Angeles

Craig Williams, PharmD (2014 Chair)
Clinical Professor
Department of Pharmacy Practice
Oregon Health & Science University